Michael J Higgins's most recent trade in Voyager Therapeutics Inc was a trade of 24,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | Michael J. Higgins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Cyclerion Therapeutics Inc | Michael J. Higgins | Director | Grant, award, or other acquisition of securities at price $ 2.75 per share. | 25 Mar 2025 | 9,090 | 30,740 (0%) | 0% | 2.8 | 24,998 | Common Stock |
| Voyager Therapeutics Inc | Michael J. Higgins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Michael J. Higgins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Michael J. Higgins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 2,436 | 2,436 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Michael J. Higgins | Director | Sale of securities on an exchange or to another person at price $ 6.70 per share. | 14 Jul 2022 | 13,891 | 31,314 (0%) | 0% | 6.7 | 93,070 | Common Stock |
| Voyager Therapeutics Inc | Michael J. Higgins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Michael J. Higgins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 36,833 | 36,833 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Michael J. Higgins | Director, Interim President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2022 | 161,000 | 161,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Michael J. Higgins | Director, Interim President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2022 | 45,205 | 45,205 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Michael J. Higgins | Director, Interim President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Michael J. Higgins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |